Vaccine effectiveness monitoring
5 European H2020 organizations list this as part of their work — 4 as their primary capability.
Most active in this area
- HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO
Croatia's national public health institute contributing population health data, biomonitoring, and epidemiological expertise to pan-European health research consortia.
“I-MOVE-plus — participated in an integrated European platform measuring and comparing vaccine effects across populations.”
HR5 projects - INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE MEDICO-MILITARA CANTACUZINO
Romania's national medical-military institute specializing in vaccine monitoring, infectious disease surveillance, and One Health research across European networks.
“Core contributor to I-MOVE-plus and I-MOVE-COVID-19, both pan-European platforms measuring real-world vaccine performance across hospital and primary care networks.”
PrimaryRO4 projects - EPICONCEPT UK LIMITED
UK-based epidemiology technology SME specialising in multi-country vaccine effectiveness studies and pandemic surveillance platforms for European public health networks.
“I-MOVE-plus built a platform to measure vaccine effects across Europe, and I-MOVE-COVID-19 extended that model to SARS-CoV-2.”
PrimarySMEUK3 projects - THE COMMON SERVICES AGENCY
Scotland's national health services agency contributing epidemiological surveillance data and blood transfusion expertise to European health research networks.
“Participated in both I-MOVE-plus and I-MOVE-COVID-19, pan-European platforms measuring vaccine effects across primary care and hospital networks.”
PrimaryUK3 projects - ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA
Navarra's regional public health authority providing respiratory disease and vaccine effectiveness surveillance data to European epidemiology networks.
“Both I-MOVE-plus and I-MOVE-COVID-19 explicitly include vaccine effectiveness measurement as a core objective, covering influenza and COVID-19 respectively.”
PrimaryES2 projects